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Human immunodeficiency virus type 1 (HIV-1) NDK, a Zairian subtype D virus highly cytopathic for CD4-positive lympho-
cytes, and the prototype subtype B virus HIV-1 LAV are about 104 and 105 times more infectious, respectively, for T
lymphocytes than for blood-derived macrophages (BDM). Recombinant viruses derived from HIV-1 LAV and HIV-1 NDK
were used to determine the genetic control and the step of the virus/cell cycle responsible for infection of BDM with T-
cell-tropic viruses. We found that recombinants bearing the envelope glycoprotein of HIV-1 NDK are able to enter more
efficiently into BDM than recombinants with HIV-1 LAV envelope glycoprotein. We also found that a genetic region outside
of the env gene is responsible for production of HIV-1 NDK infectious progeny from BDM. This region consists of the vif
gene and the C- and N-terminal portions of pol and vpr genes, respectively. Our results suggest that productive infection
of primary macrophages with T-cell-tropic strains of HIV-1 is determined by two different genetic mechanisms: one effective
at the virus/cell entry, controlled by the env gene, and the second after entry, controlled by genes vif and vpr. In comparison
with HIV-1 LAV, HIV-1 NDK has been able to more easily overcome both restriction mechanisms. q 1996 Academic Press, Inc.
Numerous genetic studies have demonstrated the im- the restriction after entry. We focused our interest on the
portance of the env gene for HIV-1 host-range tropism role of the envelope glycoprotein gene and of accessory
(1–6) and identified virus entry into the cell as a critical genes in the control of these processes. To characterize
step for infection of both major target cell systems, T the genetic control of productive infection of BDM with
lymphocytes and monocytes/macrophages. Our group T-cell-tropic strains of HIV-1, we used recombinants de-
(7) and others (8 – 10) have shown that T-cell-tropic vi- rived from HIV-1 LAV, the subtype B prototype virus, and
ruses are able to enter and to retrotranscribe their ge- HIV-1 NDK, a Zairian subtype D virus highly cytopathic
netic material in blood-derived macrophages (BDM). We for CD4-positive lymphocytes (19, 20). HIV-1 NDK has a
concluded that restriction of T-cell-tropic HIV-1 isolates broader host-cell range than HIV-1 LAV and, after enter-
in BDM is controlled at some postentry step of the virus ing the cell, it is able to more easily overcome the intra-
replication cycle. The restriction event has been associ- cellular block of viral reproduction (7, 21–24).
ated with a step prior to or simultaneous with the integra- Infection of BDM with HIV-1 NDK was at least 10 times
tion of the HIV-1 genome (10). Recent mutational studies more effective than with HIV-1 LAV (Table 1). At least 10
have shown that the matrix (MA) protein p18gag (11) and ng of p24gag of HIV-1 NDK was necessary to productively
the ‘‘nonessential’’ HIV-1 accessory genes vif (12–14), infect a culture of 5 1 105 BDM. This threshold value
vpr, vpu, and nef (14 – 16) are required for replication was 10,000 times higher than the minimal infectious dose
of HIV-1 in BDM. Functional characterization of mutant for peripheral blood lymphocytes (PBL) or MT4 lympho-
viruses revealed that MA and vpr genes are necessary cytes. Quantity of the output HIV-1 NDK virus produced
for transport and penetration of the HIV-1 nucleoprotein by BDM infected with 10 to 1000 ng of p24gag reached
complex into the nondividing nucleus (11, 17, 18), and about 0.5% of the amount of input virus (Table 1). Taken
that genes vif and vpu are involved in maturation of virus together, HIV-1 NDK and HIV-1 LAV were about 104 and
particles in primary cells. vif is also crucial for synthesis 105 times more infectious, respectively, for T lymphocytes
of HIV-1 provirus in infected cells (12). These studies than for macrophages.
have suggested that accessory genes could play a role To understand the mechanism responsible for the dif-
in control of postentry restriction in BDM. ferent outcomes of infection of BDM with HIV-1 LAV and
In the present report we studied the importance of HIV-1 NDK, we tried to determine at which step of the
HIV-1 restriction at virus entry into BDM as opposed to virus cell cycle the differences occurred and which
gene(s) is responsible for its control. For this purpose,
BDM were infected with several recombinants from our1 To whom reprint requests should be addressed. Fax: (33) 91 41 92
50. collection of chimeric viruses (Fig. 1) and replication was
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TABLE 1 monitored by PCR (Fig. 2). High sensitivity of HIV-1 repli-
cation to AZT, a known inhibitor of reverse transcriptase,Replication of HIV-1 in PBL and BDM Cellsa
demonstrated that a PCR signal reflected newly synthe-
BDM tized HIV-1 DNA and not HIV-1 DNA which originated
PBL from virus stocks either in a free form or present within
p24gag p24gag infectious virions (Fig. 2). All recombinants bearing the
HIV-1 (ng/ml) (ng/ml) TCIDMT4/ml HIV-1 NDK envelope glycoproteins (Fig. 1, lines b, d, e,
h, i, j, and k) entered BDM about 10 times more efficientlyInput virusb
PAR 10.0 0.01 ND (Fig. 2) than recombinants with envelope glycoprotein of
NDK 0.001 10.0 104 HIV-1 LAV (Fig. 1, lines a and c). The amplification signal
LAV 0.01 100.0 105 from BDM infected with HIV-1 NDK was about 10 times
Output virusc
weaker than that from BDM infected with control macro-PAR 28 89.5 10
phage-tropic strain HIV-1 PAR. This result suggests thatNDK 358 3.6 103
LAV 391 0.29 £10 env gene variants occurring among different T-cell-tropic
strains have an importance for virus entry into BDM that
a PBL (106) or BDM (5 1 105) cells were infected in a final volume is similar to that of those occurring between T-cell-tropic
of 1 ml as described previously (7).
and macrophage-tropic viruses.b Minimal infectious dose of HIV-1 necessary for productive infection
Ample experimental evidence (25–28) has shown thatof 106 PBL or 5 1 105 BDM cells were determined by end-point dilution
of viral stock. Infection with a higher dilution of input virus did not result HIV-1 NDK has more pronounced syncytia-inducing (SI)
in virus production. p24gag was determined by the antigen capture phenotype than HIV-1 LAV. Such a phenotype of HIV-1
technique (Coulter, Inc., Hialeah, FL; HIV-1 p24 antigen assay), TCIDMT4 NDK could also be predicted from comparison of the
by titration in MT4 cells (26). HIV-1 LAV and NDK were prepared in
amino acid sequences of V2 and V3 regions of gp120 ofPBL. Macrophage-tropic strain HIV-1 PAR (29) was prepared in cord
both viruses (4, 5). Therefore, according to the classifica-blood lymphocytes (7 ).
c Output virus production was determined at the peak of virus produc- tion of SI/NSI isolates, HIV-1 LAV could be expected to be
tion after infection of 106 PBL or 5 1 105 BDM cells with 600 ng of more macrophage-tropic than HIV-1 NDK. This contrasts
p24gag of each input virus. with experimental results and suggests that another
structural feature(s) of the HIV-1 NDK envelope glycopro-
FIG. 1. Genetic control of BDM infection with T-cell-tropic viruses. Recombinant provirus molecules derived from DNA cloned from HIV-1 LAV
(dotted lines) and HIV-1 NDK (solid lines) were constructed by reciprocal exchange of genetic material using conserved BssHII255 , SpeI1042 , EcoRI4183 ,
EcoRI5278 , and XhoI8401 sites (25–27) or by PCR-directed recombination (23). Recombinants UFOPR (line j) and UFRPO (line k) constructed by PCR-
directed recombination were obtained from recombinant LDPE by reciprocal exchange of HIV-1 LAV and NDK fragments EcoRI4183 –5095 and 5153–
EcoRI5278 , respectively. They contained complete vpr (UFOPR) and vif (UFRPO) genes of HIV-1 NDK. The positions of restriction sites are indicated
for the HIV-1 NDK sequence. Chimeric viruses were obtained by cocultivation of transfected COS cells with PBL (25). Columns under virus production:
(1) Virus production from BDM infected with 100 ng of p24gag of input virus; (2) Virus titer, expressed as TCIDMT4 , was determined in an end-point
dilution assay of BDM-free supernatants obtained 15 days p.i. as measured by formation of cytopathic effects (CPE) in MT4 cells. £, CPE was
found only in nondiluted supernatants of some experiments. (3) The fusogenicity of different recombinant viruses was determined by syncytia
formation on MT4 cells (25). Subcultures of MT4 cells infected with different recombinants were coded and the sizes of syncytia were scored
independently by two researchers each 3rd day over a 2-week period. The morphology of syncytia is indicated by / for standard-size syncytia
induced by the HIV-1 LAV prototype and by /// for large syncytia induced by the highly cytopathic strain HIV-1 NDK. n.d., not determined.
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tion period in the presence of AZT. They ranged from 10
to 30% of the control value, probably due to a release
of the input virus which was adsorbed but failed to be
internalized by BDM. p24gag amounts were reduced to
less than 2% after the first change of AZT-containing
medium. This means that the great majority of p24gag
detected after infection of BDM with T-cell-tropic viruses
corresponded to newly synthesized virus.
Recombinants LDPE and LDGP (Fig. 1, lines h and i),
which contained the HIV-1 NDK region p34int-env (frag-
ment EcoRI4183 –XhoI8401) reproducibly produced more
p24gag antigen than the recombinant NLDE (Fig. 1, line
d), bearing a shorter HIV-1 NDK fragment EcoRI5276 –
XhoI8401 . All recombinants which contained the HIV-1
LAV envelope glycoprotein produced at least 10 times
less of the virus (Fig. 1, lines a, c, f, and g and Fig. 3) in
agreement with the lower efficiency of their entry into
BDM. These results confirm that (i) envelope glycopro-
tein(s) of T-cell-tropic viruses genetically controls restric-
FIG. 2. HIV-1 DNA synthesis in BDM infected with lymphotropic
tion of productive infection at the virus/cell entry, andrecombinant viruses. BDM (5 1 105) were infected with about 100 ng
suggest that (ii) additional genes different from env areof p24gag of recombinant HIV-1 (Fig. 1) or macrophage-tropic virus HIV-
1 PAR. All viral stocks were treated with 200 U of DNaseI/ml for 30 necessary for an efficient replication of HIV-1 NDK after
min at room temperature before use. Retrotranscription of HIV-1 geno- its entry in BDM.
mic RNA was monitored by DNA amplification 48 hr p.i. Cell lysates In seven independent experiments, BDM infected with
were prepared and the amplification reaction was carried out as de-
100 ng of the HIV-1 NDK p24gag produced 102 to 103 tissuescribed previously (7). Intermediate gag primers (30) were localized at
culture infectious units (Figs. 1 and 4) as determined inthe following positions of HIV-1 LAV sequence: gag / primer A1 (882–
909), gag 0 primer A2 (1177– 1204), and gag probe CBIO (949–976). the MT4 assay (TCIDMT4). In BDM infected with HIV-1
PCR amplification products of gag gene were visualized after Southern LAV, infectious progeny was only detected in nondiluted
blot hybridization with 32P-labeled oligonucleotide probes. Amounts of supernatants in three of seven experiments. Phenotypic
genomic DNA present in different cell lysates were detected by PCR
analysis revealed that reciprocal exchange between HIV-of the first intron of the human b-globin gene (28). The quantity of
1 LAV and NDK env gene (EcoRI5278 –XhoI8401 fragments)PCR products was estimated according to decadic dilutions of Gene
Amplimer HIV-1 Positive Control DNA (Perkin–Elmer Cetus, Inc., Nor- resulted in recombinants that were not able to form a
walk, CT). higher quantity of infectious progeny than the prototype
virus (Fig. 1, lines c and d). This indicates that parts of
tein(s) is involved in interaction with BDM. We have the HIV-1 NDK genome inside as well as outside of this
shown previously (28) that the envelope glycoprotein is fragment have contributed to the production of an infec-
involved in the enhanced resistance of HIV-1 NDK to
treatment of target cells with OKT4-A anti-CD4 MAb and
suggested that HIV-1 NDK might be able to use a CD4-
independent mechanism of virus/cell entry into CD4-pos-
itive cells. Such a mechanism could be responsible for
the efficient entry of HIV-1 NDK in BDM.
To characterize the region(s) of the HIV-1 genome re-
sponsible for the control of productive infection of BDM
with T-cell-tropic virus, we infected BDM with viral recom-
binants and followed their replication kinetics by p24gag
antigen capture assay (Figs. 1 and 3). In seven indepen-
dent experiments in which macrophages from two
healthy donors were used, the highest quantity of capsid
antigen was produced by parental clone HIV-1 Y-NDK. It
ranged from 0.2 to 1% of the input virus and was stable
for about 4 weeks p.i. Levels of p24gag antigen detected
FIG. 3. Replication kinetics of recombinants of T-cell-tropic HIV-1 inin supernatants of BDM infected with macrophage-tropic
BDM. BDM (5 1 105) were infected with about 100 ng of p24gag ofvirus HIV-1 PAR were about 50 times higher. Virus pro-
recombinant HIV-1 (Fig. 1) or macrophage-tropic virus HIV-1 PAR. Virus
duction was highly sensitive to the presence of AZT in production was determined by p24gag antigen capture assay. The cutoff
the culture medium (Fig. 3). Small amounts of p24gag were value was 7 pg/ml. The culture medium was completely changed every
5 days.transiently detected during the first 5 days of the cultiva-
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FIG. 4. Production of an infectious progeny from BDM infected with T-cell-tropic recombinant viruses. BDM (5 1 105) were infected with about
100 ng of p24gag of recombinant HIV-1 (Fig. 1) and the infectious titer was determined by MT4 assay. The culture medium was completely changed
every 5 days. The cutoff value in these experiments was equal to 10 TCIDMT4/ml.
tious progeny observed in the case of HIV-1 NDK. Also, LDPE. Among the 192 amino acids (aa) of Vif, 15 differ
between HIV-1 LAV and HIV-1 NDK. Some of these sub-BDM supernatants infected with recombinants con-
taining the HIV-1 NDK MA gene, individually or simultane- stitutions, localized at both terminal portions of Vif (R r
S, aa 23; K r N, aa 36; D r R, aa 37; K r A, aa 155; Qously with the HIV-1 NDK EcoRI5278 –XhoI8401 fragment
(Fig. 1, lines e and f) or the HIV-1 NDK fragment r K, aa 158; H r R, aa 183), could be important for protein
function. In contrast, only one amino acid substitution (NEcoRI4183 – EcoRI5278 (Fig. 1, line g), remained noninfec-
tious. Only recombinants containing the HIV-1 NDK re- r S, aa 41) is present in the N-terminal portion of Vpr.
Despite the high variability in the vif gene and low vari-gion p34int-env (fragment EcoRI4183 –XhoI8401 , Fig. 1, lines
h and i) produced virus infectious for T lymphocytes in ability in the vpr gene, both HIV-1 NDK genes contributed,
in addition to the env gene, to the enhanced capacity ofBDM cell-free supernatants. Selective advantage of HIV-
1 NDK in CD4-positive lymphocytes is related to varia- HIV-1 NDK to produce infectious progeny in BDM.
Our results indicate that two genetic mechanisms, onetions in gag–pol genes (26) and in the MA gene together
with the gene coding for the envelope glycoprotein (23, effective at virus entry and the other after entry, determine
differences in replication of T-cell-tropic viruses in BDM.28). Very different results obtained in BDM provide an
intrinsic control which argues against the possibility that These mechanisms are controlled by the envelope glyco-
protein gene and by the accessory genes vif and vpr.contaminating lymphocytes in the macrophage cultures
contributed to the observed patterns of replication of T- Both accessory genes vif and vpr are involved in early
steps of virus cycle before formation of HIV-1 proviruscell-tropic viruses in BDM.
The genetic structure of the fragment EcoRI4183 – (12, 18). In comparison with the majority of previous stud-
ies aimed at investigating restriction either at the virusEcoRI5278 is quite complex. In addition to the vif gene, it
contains the N-terminal portion of the vpr gene and the entry level or after entry, we have been able to demon-
strate and quantitate both restriction mechanisms in oneC-terminal portion of p34int gene. In order to characterize
more precisely the genetic region(s) of HIV-1 NDK re- homogeneous system of recombinants. A principal role
of the env gene in the control of the tropism for macro-sponsible for infection of BDM, genetically defined vif
and vpr recombinants were constructed by PCR-directed phages and T cells at the virus entry level has been
described by many groups of investigators (1–6). Therecombination within EcoRI4183 –EcoRI5278 fragment (Fig.
1, lines j and k). vif and vpr genes present in the prototype mechanism and genetic control of restriction after entry
is much less well documented. The present results indi-virus HIV-1 LAV (parental clone LB) are isogenic with
the genes present in the macrophage-tropic recombinant cate that a higher functional activity of vif and vpr alleles
of HIV-1 NDK is related to its ability to more easily over-virus NF462 (14). Therefore, both genes are fully compati-
ble with replication of HIV-1 in BDM. Reciprocal ex- come postentry restriction in BDM. Role of accessory
genes in the control of macrophage-tropic phenotype haschange of the HIV-1 LAV and NDK genes vif and vpr in
the provirus LDPE produced the recombinants UFOPR previously been studied by inactivation of gene function
by in vitro mutagenesis (13–16). In the present report weand UFRPO. Both recombinants produced intermediate
quantities of p24gag between HIV-1 NLDE and LDPG (Fig. have compared activities of ‘‘wild-type’’ alleles of vif and
vpr genes of HIV-1 LAV and NDK. Our results provide3). More significant differences were found in the produc-
tion of infectious progeny from BDM (Fig. 4); the transient evidence that natural variation in the wild-type alleles of
vif and vpr genes is related to quantitative differencesproduction of the HIV-1 UFOPR and UFRPO infectious
progeny ceased 15 days before that of HIV-1 LDPG and in phenotypic behavior of HIV-1 strains. Both types of
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